Article
CpG island methylator phenotype in cancer.
Nature reviews. Cancer - 1 Dec 2004
Issa Jean-Pierre
Abstract excerpt
DNA hypermethylation in CpG-rich promoters is now recognized as a common feature of human neoplasia. However, the pathophysiology of hyper-methylation (why, when, where) remains obscure. Cancers can be classified according to their degree of methylation, and those cancers with high degrees of methylation (the CpG island methylator phenotype, or CIMP) represent a clinically and aetiologically distinct group that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
